Extract from M&A Insights

The below story was originally featured in our daily M&A Insights Newsletter. Selected stories, including this one, are posted to our website with a few weeks of delay.
Navamedic proposes IPO for Medtech division
May 15, 2019

Navamedic intends to spin-off and separately list its Medtech division on the Oslo Stock Exchange in the third quarter of 2019. The division is commercializing Sippi, a system for digital urine measurement. According to Navamedic, the long-term annual revenue potential of Sippi is estimated to excess NOK 250m. Carnegie has been retained as advisor for the listing.

ⓘ This story was originally featured in our daily M&A Insights newsletter.
Our insights have been covered by: